Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Elderly Face More Complications in Rectal Cancer Surgery
June 2025
Research shows patients over 70 experience more complications and a higher death rate following rectal cancer surgery compared to younger patients.
Read more
9 Jun 2025
Elderly Face More Complications in Rectal Cancer Surgery
Research shows patients over 70 experience more complications and a higher death rate following rectal cancer surgery compared to younger patients.
8 Jun 2025
Midlife Health Conditions Linked to Increased Cancer Risk
A new study of nearly 129,000 adults has revealed that common midlife comorbidities, such as respiratory and cardiovascular conditions, are associated with an increased risk of cancer and cancer-related death.
25 May 2025
ESMO Breast Cancer 2025: Taxane Chemotherapy Boosts Survival in Advanced Breast Cancer
A recent multi-centre study reveals taxane-based chemotherapy is linked to markedly better one-year survival in advanced triple-negative breast cancer with genomic instability, compared to platinum-based treatments.
25 May 2025
CT Scan Radiation May Lead to Thousands of Future Cancers
A new study has projected that radiation exposure from computed tomography (CT) scans in the United States will result in approximately 103,000 future cancers.
24 May 2025
ESMO Breast Cancer 2025: Gut Microbiome Linked to Breast Cancer Recurrence
New research presented at ESMO Breast 2025 reveals that certain gut bacteria and microbial functions are more common in breast cancer patients who later experience recurrence, highlighting the potential of the gut microbiome as a biomarker for relapse risk.
24 May 2025
ESMO Breast Cancer 2025: Alcohol Increases Breast Cancer Risk but Not Prognosis
New research presented at ESMO Breast 2025 shows that alcohol consumption raises the risk of developing breast cancer, particularly hormone receptor-positive types, but does not appear to worsen survival or recurrence in those already diagnosed.
24 May 2025
ESMO Breast Cancer 2025: DNA Repair Mutations May Reduce Therapy Response
New data from ESMO Breast 2025 indicate that inherited DNA repair mutations could affect the effectiveness of CDK4/6 inhibitors in treating advanced breast cancer, with mutation carriers showing lower response rates and shorter survival trends.
23 May 2025
ESMO Breast Cancer 2025: Short-Course Radiotherapy Safe After Breast Cancer Surgery
New data presented at ESMO Breast 2025 show that short-course radiotherapy offers similar survival outcomes to conventional treatment following surgery and nodal irradiation for breast cancer.
Loading posts...
1
2
3
…
50
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View